Inventor · disambiguated record
Eddy Jean Edgard Freyne
Also filed as: FREYNE EDDY J E · FREYNE EDDY JEAN · FREYNE EDDY JEAN E · FREYNE EDDY JEAN EDGARD
76 granted patents·10 pending applications·839 citations·filing 1986–2021
99Inventor score
Files withJANSSEN PHARMACEUTICA NV52FREYNE EDDY JEAN EDGARD12ASTEX THERAPEUTICS LTD5SAXTY GORDON3VIALARD JORGE EDUARDO2
Top patents by PatentIndex Score
86 records- 0196US4859684A(1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives and use thereof in treating androgen dependent disordersJANSSEN PHARMACEUTICA NV·Filed 1987·Granted Aug 22, 1989·65 cites·20 claims
- 0295US9850228B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2016·Granted Dec 26, 2017·17 cites·5 claims
- 0395US9464071B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Oct 11, 2016·24 cites·45 claims
- 0495US7514445B2Heteroaryl amines as glycogen synthase kinase 3β inhibitors (GSK3 inhibitors)JANSSEN PHARMACEUTICA NV·Filed 2002·Granted Apr 7, 2009·117 cites·8 claims
- 0595US5037829A(1H-azol-1-ylmethyl) substituted quinazoline derivativesJANSSEN PHARMACEUTICA NV·Filed 1989·Granted Aug 6, 1991·57 cites·20 claims
- 0695US5028606A(1H-azol-1-ylmethyl)substituted quinoxaline derivativesJANSSEN PHARMACEUTICA NV·Filed 1989·Granted Jul 2, 1991·44 cites·13 claims
- 0794US8895601B2Pyrazolyl quinoxaline kinase inhibitorsSAXTY GORDON·Filed 2011·Granted Nov 25, 2014·25 cites·36 claims
- 0891US5521187A1,3-Dihydro-2H-imidazo[4,5-B]quinolin-2-one derivativesJANSSEN PHARMACEUTICA NV·Filed 1992·Granted May 28, 1996·41 cites·21 claims
- 0990US10519137B2Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2017·Granted Dec 31, 2019·6 cites·18 claims
- 1089US8481531B2Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic useSAXTY GORDON·Filed 2010·Granted Jul 9, 2013·9 cites·20 claims
- 1188US8476289B2Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylaceFREYNE EDDY JEAN EDGARD·Filed 2009·Granted Jul 2, 2013·12 cites·9 claims
- 1288US8299256B2Quinolinone derivatives as PARP and TANK inhibitorsVIALARD JORGE EDUARDO·Filed 2008·Granted Oct 30, 2012·17 cites·9 claims
- 1386US5151421A(1h-azol-1-ylmethyl) substituted quinoxaline derivativesJANSSEN PHARMACEUTICA NV·Filed 1991·Granted Sep 29, 1992·29 cites·6 claims
- 1485US7655642B23-cyano-quinoline derivatives with antiproliferative activityJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Feb 2, 2010·13 cites·5 claims
- 1584US7799772B2Pyrido-and pyrimidopyrimidine derivatives as anti-profilerative agentsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Sep 21, 2010·16 cites·6 claims
- 1684US4943574A(1H-azol-1-ylmethyl) substituted benzotriazole derivatives and pharmaceutical compositions containing themJANSSEN PHARMACEUTICA NV·Filed 1989·Granted Jul 24, 1990·23 cites·11 claims
- 1783US8394786B2Quinazoline derivativesFREYNE EDDY JEAN EDGARD·Filed 2009·Granted Mar 12, 2013·5 cites·8 claims
- 1882US8148388B22,4 (4,6) pyrimidine derivativesFREYNE EDDY JEAN EDGARD·Filed 2005·Granted Apr 3, 2012·6 cites·31 claims
- 1982US7648975B2Macrocyclic quinazoline derivatives as antiproliferative agentsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Jan 19, 2010·12 cites·8 claims
- 2081US5491161APyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole derivativesJANSSEN PHARMACEUTICA NV·Filed 1995·Granted Feb 13, 1996·24 cites·4 claims
- 2180US6358961B1Farnesyltransferase inhibiting quinazolinonesJANNSEN CILAG S A·Filed 2000·Granted Mar 19, 2002·17 cites·1 claims
- 2278US7947695B25-membered annelated heterocyclic pyrimidines as kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted May 24, 2011·4 cites·19 claims
- 2378US7449465B2Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Nov 11, 2008·12 cites·17 claims
- 2478US6177432B1Farnesyltransferase inhibiting quinazolinonesJANSSEN CILAG S A·Filed 1998·Granted Jan 23, 2001·40 cites·12 claims
- 2577US7560458B2Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Jul 14, 2009·9 cites·16 claims
- 2677US5516908A1,3-dihydro-2H-imidazo-[4,5-β]quinolin-2-one derivatives and intermediatesJANSSEN PHARMACEUTICA NV·Filed 1995·Granted May 14, 1996·17 cites·8 claims
- 2777US5043327APositive inotropic and lusitropic 3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one derivatives, compositions and useJANSSEN PHARMACEUTICA NV·Filed 1990·Granted Aug 27, 1991·17 cites·15 claims
- 2877US2022135544A1Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2975US8778966B2Quinolinone derivatives as PARP and tank inhibitorsVIALARD JORGE EDUARDO·Filed 2012·Granted Jul 15, 2014·3 cites·6 claims
- 3074US8168644B2Quinazolinone derivatives as tubulin polymerization inhibitorsFREYNE EDDY JEAN EDGARD·Filed 2009·Granted May 1, 2012·2 cites·7 claims
- 3173US8796244B2Imidazopyridine derivatives as inhibitors of receptor tyrosine kinasesBERDINI VALERIO·Filed 2009·Granted Aug 5, 2014·2 cites·21 claims
- 3273US7947694B2Substituted pyrazolo[3,4-D]pyrimidines as cell cycle kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted May 24, 2011·2 cites·16 claims
- 3373US6911444B2Non-steroidal IL-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitorsJANSSEN PHARMACEUTICS N V·Filed 2002·Granted Jun 28, 2005·10 cites·13 claims
- 3473US5612354A(1H-azol-1-ylmethyl)substituted quinoline derivativesJANSSEN PHARMACEUTICA NV·Filed 1995·Granted Mar 18, 1997·13 cites·9 claims
- 3568US8492377B2MTKI quinazoline derivativesPAPANIKOS ALEXANDRA·Filed 2007·Granted Jul 23, 2013·2 cites·15 claims
- 3668US2020131153A1Pyrazolyl quinoxaline kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 3767US9365517B23-cyano-quinoline derivatives with antiproliferative activityJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 14, 2016·0 cites·1 claims
- 3867US8778920B23-cyano-quinoline derivatives with antiproliferative activityFREYNE EDDY JEAN EDGARD·Filed 2009·Granted Jul 15, 2014·0 cites·6 claims
- 3966US6403805B11,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatvesJANSSEN PHARMACEUTICA NV·Filed 1999·Granted Jun 11, 2002·20 cites·16 claims
- 4065US4826862AAnthelminthic [(5(6) (1H-azole-1-ylmethyl)benzimidazole]carbamatesJANSSEN PHARMACEUTICA NV·Filed 1988·Granted May 2, 1989·11 cites·9 claims
- 4164US9040511B23-cyano-quinoline derivatives with antiproliferative activityJANSSEN PHARMACEUTICA NV·Filed 2013·Granted May 26, 2015·0 cites·4 claims
- 4263US7241763B23-furanyl analogs of toxoflavine as kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Jul 10, 2007·2 cites·17 claims
- 4363US6743792B26-azauracil derivatives as IL-5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Jun 1, 2004·1 cites·18 claims
- 4462US5994376A1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one compounds and their use for treating allergic, atopic or inflammatory diseasesJANSSEN PHARMACEUTICA NV·Filed 1996·Granted Nov 30, 1999·17 cites·16 claims
- 4562US5541325AIntermediates for the preparation of 1,3,dihydro-2H-imidazo[4,5-B]quinolin-2-one derivativesJANSSEN PHARMACEUTICA NV·Filed 1995·Granted Jul 30, 1996·7 cites·4 claims
- 4661US5256681A[5(6)-(benzisoxa-,benzisothia-or indazol-3-yl)-1H-benzimidazol-2-yl]carbamatesJANSSEN PHARMACEUTICA NV·Filed 1989·Granted Oct 26, 1993·5 cites·7 claims
- 4759US8933067B2Pyrido and pyrimidopyrimidine derivatives as anti-profilerative agentsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jan 13, 2015·0 cites·8 claims
- 4859US6583141B14,5-dihydro-isoxazole derivatives and their pharmaceutical useJANSSEN PHARMACEUTICA NV·Filed 1999·Granted Jun 24, 2003·18 cites·15 claims
- 4958US10208062B2Macrocyclic quinazole derivatives and their use as MTKIJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Feb 19, 2019·0 cites·2 claims
- 5058US9273013B2Quinazoline derivativesJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Mar 1, 2016·0 cites·1 claims
Showing the top 50 of 86 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Eddy Jean Edgard Freyne files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →